Edward Hartsough, Ph.D. received a post-doctoral fellowship from the National Cancer Center Organization ( http://www.nationalcancercenter.org/ ). The fellowship grant is entitled “Next-Generation RAF Inhibitors in V600E BRAF Melanoma.” Dr. Hartsough works in Dr. Andrew Aplin’s lab at the Kimmel Cancer Center.
The National Cancer Center was founded by Dr. J. Ernest Ayre in 1953 as a non-profit organization committed to research and education about cancer. Melanoma is the deadliest form of skin cancer and its incidence is on the rise. BRAF mutations are found in half of melanomas and the funded work will study new mutant BRAF targeting agents in preclinical models.